| Literature DB >> 30995477 |
Sheikh Rayees1, Jagdish Chandra Joshi1, Mohammad Tauseef2, Mumtaz Anwar1, Sukriti Baweja1, Ian Rochford1, Bhagwati Joshi1, Morley D Hollenberg3, Sekhar P Reddy4, Dolly Mehta5.
Abstract
Alveolar macrophages (AMs), upon sensing pathogens, trigger host defense by activating toll-like receptor 4 (TLR4), but the counterbalancing mechanisms that deactivate AM inflammatory signaling and prevent lethal edema, the hallmark of acute lung injury (ALI), remain unknown. Here, we demonstrate the essential role of AM protease-activating receptor 2 (PAR2) in rapidly suppressing inflammation to prevent long-lasting injury. We show that thrombin, released during TLR4-induced lung injury, directly activates PAR2 to generate cAMP, which abolishes Ca2+ entry through the TRPV4 channel. Deletion of PAR2 and thus the accompanying cAMP generation augments Ca2+ entry via TRPV4, causing sustained activation of the transcription factor NFAT to produce long-lasting TLR4-mediated inflammatory lung injury. Rescuing thrombin-sensitive PAR2 expression or blocking TRPV4 activity in PAR2-null AMs restores their capacity to resolve inflammation and reverse lung injury. Thus, activation of the thrombin-induced PAR2-cAMP cascade in AMs suppresses TLR4 inflammatory signaling to reinstate tissue integrity. Published by Elsevier Inc.Entities:
Keywords: Ca(2+) entry; NFAT; TRPV4; acute lung injury; alveolar macrophages; cAMP; protease-activating receptor 2
Mesh:
Substances:
Year: 2019 PMID: 30995477 PMCID: PMC6485424 DOI: 10.1016/j.celrep.2019.03.053
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423